Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2021-09-22 00:00:00 ET · period of report 2021-09-20 · accession 0001493152-21-023408 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-22 | 2021-09-20 | ABEO | O'Malley Brendan M. | SVP, GC | A - Grant | $0.00 | +136.0K | 273.5K | +99% | $0 |
| D | 2021-09-22 | 2021-09-20 | ABEO | O'Malley Brendan M. | SVP, GC | A - Grant | $0.00 | +272.0K | 272.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2021-09-20 | A | A | 136,000 | $0.00 | 273,454 | D | — | — | (F1) The restricted stock will vest 25% on each of September 20, 2022, September 20, 2023, September 20, 2024 and September 20, 2025. |
| 2 | Derivative | Stock Option (right to buy) | 2021-09-20 | A | A | 272,000 | $0.00 | 272,000 | D | $1.21 · — to 2031-09-20 | 272,000 Common Stock | (F2) The options will vest 25% on September 20, 2022, and in 36 equal monthly installments thereafter. |